Gosebruch Henry O
- SEC CIK
- 0001659625
No open-market purchases or sales filed in the past year.
Current role at each company
- ANIP Ani Pharmaceuticals IncDirectoras of Aug 27, 2026
- SLRN ACELYRIN, Inc.Directoras of May 23, 2025
- NMRA Neumora Therapeutics, Inc.President & CEOas of Feb 16, 2024
- APTX Aptinyx Inc.Directoras of May 31, 2022
- ABBV AbbVie Inc.EVP, Chief Strategy Officeras of May 20, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gosebruch Henry O as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NMRA Neumora Therapeutics, Inc.
President & CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 (view filing) | Sep 19 | Same day | Gosebruch Henry OPresident & CEO | PPurchase | +15.0K | $12.62 | +$189.3K | New position15.0K after |
SLRN ACELYRIN, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2023 (view filing) | May 9 | 2 days | Gosebruch Henry ODirector | PPurchase | +50.0K | $18.00 | +$900.0K | New position50.0K after |
ABBV AbbVie Inc.
EVP, Chief Strategy Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 (view filing) | May 16 | 4 days | Gosebruch Henry OEVP, Chief Strategy Officer | SSaleCommon Stock, $0.01 par value | −84.0K | $155.00 | −$13.0M | −66.9%41.6K after | Amended |
| May 20, 2022 (view filing) | Mar 1 | 80 days | Gosebruch Henry OEVP, Chief Strategy Officer | SSaleCommon Stock, $0.01 par value | −25.0K | $147.29 | −$3.68M | −31.8%53.5K after | Amended4 lots |
| Mar 1, 2022 (view filing) | Mar 1 | Same day | Gosebruch Henry OEVP, Chief Strategy Officer | SSaleCommon Stock, $0.01 par value | −15.0K | $148.26 | −$2.22M | −26.5%41.6K after | 3 lots |